Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

De novo electrocardiographic abnormalities in persons living with HIV

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Detection of biological signals from a live mammalian muscle using an early stage diamond quantum sensor

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Multichannel anodal tDCS over the left dorsolateral prefrontal cortex in a paediatric population

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Interindividual variability of electric fields during transcranial temporal interference stimulation (tTIS)

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

Persons living with HIV (PLWH) may have increased incidence of cardiovascular events and longer QTc intervals than uninfected persons. We aimed to investigate the incidence and risk factors of de novo major electrocardiogram (ECG) abnormalities and QTc prolongation in well-treated PLWH. We included virologically suppressed PLWH without major ECG abnormalities, who attended the 2-year follow-up in the Copenhagen comorbidity in HIV infection (COCOMO) study. ECGs were categorized according to Minnesota Code Manual. We defined de novo major ECG abnormalities as new major Minnesota Code Manual abnormalities. Prolonged QTc was defined as QTc > 460 ms in females and QTc > 450 ms in males. Of 667 PLWH without major ECG abnormalities at baseline, 34 (5%) developed de novo major ECG abnormalities after a median of 2.3 years. After adjustment, age (RR: 1.57 [1.08-2.28] per decade older), being underweight (RR: 5.79 [1.70-19.71]), current smoking (RR: 2.34 [1.06-5.16]), diabetes (RR: 3.89 [1.72-8.80]) and protease inhibitor use (RR: 2.45 [1.27-4.74) were associated with higher risk of getting de novo major ECG abnormalities. Of PLWH without prolonged QTc at baseline, only 11 (1.6%) participants developed de novo prolonged QTc. Five percent of well-treated PLWH acquired de novo major ECG abnormalities and protease inhibitor use was associated with more than twice the risk of de novo major ECG abnormalities. De novo prolonged QTc was rare and did not seem to constitute a problem in well-treated PLWH.

OriginalsprogEngelsk
Artikelnummer20750
TidsskriftScientific Reports
Vol/bind11
Udgave nummer1
ISSN2045-2322
DOI
StatusUdgivet - 21 okt. 2021

Bibliografisk note

© 2021. The Author(s).

ID: 68560224